TY  - GEN
AU  - Fernandez,O
AU  - Arnal-Garcia,C
AU  - Arroyo-Gonzalez,R
AU  - Brieva,Ll
AU  - Calles-Hernandez,M C
AU  - Casanova-Estruch,B
AU  - Comabella,M
AU  - de Las Heras,V
AU  - Garcia-Merino,J A
AU  - Hernandez-Perez,M A
AU  - Izquierdo,G
AU  - Matas,E
AU  - Meca-Lallana,J E
AU  - Mendibe-Bilbao,M M
AU  - Munoz-Garcia,D
AU  - Olascoaga,J
AU  - Oreja-Guevara,C
AU  - Prieto,J M
AU  - Ramio-Torrenta,Ll
AU  - Rodriguez-Antiguedad,A
AU  - Saiz,A
AU  - Tellez,N
AU  - Villar,L M
AU  - Tintore,M
AU  - Grupo Post-Ectrims,Grupo Post-Ectrims
TI  - Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)
SN  - 1576-6578
PY  - 2014///0310
KW  - Antibodies, Monoclonal
KW  - adverse effects
KW  - Apoptosis
KW  - Autoantibodies
KW  - blood
KW  - Biomarkers
KW  - Cell Differentiation
KW  - Central Nervous System Agents
KW  - therapeutic use
KW  - Cognition Disorders
KW  - etiology
KW  - Disease Progression
KW  - Europe
KW  - Forecasting
KW  - Genetic Predisposition to Disease
KW  - Immunization
KW  - Immunotherapy
KW  - Multiple Sclerosis
KW  - Myelin Sheath
KW  - pathology
KW  - Neural Stem Cells
KW  - physiology
KW  - Neuroimaging
KW  - Neurology
KW  - Oligodendroglia
KW  - Prognosis
KW  - Societies, Medical
KW  - Stem Cell Transplantation
KW  - Therapies, Investigational
KW  - Treatment Outcome
N1  - Publication Type: Congress; Research Support, Non-U.S. Gov't
ER  -